Another finding was that among AC patients, Ki values were lower in EGFR (+) patients than in EGFR (-) patients, and for some patients with non-small cell lung cancer (NSCLC) where EGFR testing is not available, Ki improved its discriminability. This evidence concerns the gene EGFR and non-small cell lung carcinoma.